home / stock / ogn / ogn news


OGN News and Press, Organon & Co. From 10/04/23

Stock Information

Company Name: Organon & Co.
Stock Symbol: OGN
Market: NYSE
Website: organon.com

Menu

OGN OGN Quote OGN Short OGN News OGN Articles OGN Message Board
Get OGN Alerts

News, Short Squeeze, Breakout and More Instantly...

OGN - Organon: The Federal Reserve Black Swan (Rating Upgrade)

2023-10-04 11:45:54 ET Summary The stock of junk-rated Organon & Co. has lost more than 40% since my first article, largely due to interest rates continuing to rise. I take a close look at the company's debt and how I think the situation will evolve until 2028 - when OGN will ...

OGN - Organon Recognized on Fortune's 2023 Change the World List for Leadership in Expanding Access to Contraceptive Choice

Her Promise Access Initiative helped prevent 57 million unplanned pregnancies putting the company approximately halfway to its goal of preventing 120 million unplanned pregnancies by 2030 Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, has been na...

OGN - On World Contraception Day, Organon Canada Declares Support for Universal Access to Contraception in Canada

On World Contraception Day, Organon Canada Declares Support for Universal Access to Contraception in Canada Canada NewsWire With nearly half of all pregnancies unintended in Canada , all sectors must work together to help tackle this public health issue KIRKLAND ...

OGN - Drugs 'n Diapers: 5 Dividends Up to 5.9%

2023-09-22 05:00:26 ET Worried that the Federal Reserve is driving our economy off a cliff? I’ve got two words for you: Drugs ‘n diapers . Actually, I forgot one. Dividends . These companies are about as recession-resistant as they come. Let’...

OGN - First Real-World Observational Study of the JADA® System, a Medical Device to Control Postpartum Hemorrhage (PPH), Published in ACOG's Obstetrics & Gynecology

JADA Rapidly and Effectively Controlled Bleeding Due to PPH, 1 Reinforcing Pivotal Study Results 1 PPH is a Significant Cause of Maternal Morbidities in the U.S. 2,3,4,5 New Exploratory Post-Hoc Analysis Examined the Relationship Between Reported Severe Maternal Morbidity (SMM...

OGN - 6% Yield And Significantly Undervalued: A Closer Look At Organon

2023-09-10 02:23:12 ET Summary Organon & Co. stock is down 30% year-to-date and 40% below its 52-week highs. OGN offers a dividend yield of 5.8%, making it an attractive option for income-oriented investors. The company has a stable revenue base and potential for future di...

OGN - 3 Pharmaceutical Stocks That Are Too Cheap to Ignore

2023-09-09 07:20:00 ET On average, healthcare stocks haven't kept up with the gains made by the rest of the market this year. While the S&P 500 index is up by more than 17% year to date, that sector's stocks are down by nearly 3%. That trend, though, created some great opportunities...

OGN - Organon Bolsters Research & Development Expertise with Two Leadership Appointments

Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, today announced the appointment of Juan Camilo Arjona Ferreira, M.D., as Chief Medical Officer (CMO) and Charlotte Owens, M.D., as Head of Medical Affairs and Outcomes Research, strengthening the companyȁ...

OGN - Orogen Royalties Announces Profitable Quarter and Strong Cashflow for Q2-2023

VANCOUVER, BC / ACCESSWIRE / August 28, 2023 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to report profitable financial results from its operations for the second quarter ended June 30, 2023. Paddy Nicol, CEO of Orogen, commented: "We are happy to re...

OGN - 3M grabs Hanson from Zimmer Biomet to lead healthcare spinoff

2023-08-22 09:23:41 ET More on 3M: 3M Company: Small Beat, Weak Guidance. Story Still All About The Liabilities 3M Company: Soaring On Earnings 3M Company: I Replaced A Loser With These Three Leaders For further details see: 3M grabs Hanson from Zimmer Bi...

Previous 10 Next 10